Oramed Pharmaceuticals Inc. - Balanse (Quarterly)

Oramed Pharmaceuticals Inc.
IL ˙ TASE ˙ US68403P2039
Balanse (Quarterly)

Oramed Pharmaceuticals Inc. Balansen viser selskapets kontosaldoer på bestemte tidspunkter. Balansen omfatter eiendeler, omløpsmidler, anleggsmidler, varige driftsmidler, varelager, immaterielle eiendeler, gjeld, kortsiktig gjeld, gjeld, leieforpliktelser, ordinære aksjer, opptjent egenkapital, egne aksjer og egenkapital.

Alle tall er ganger 1,000,000.00 med unntak av enheter per aksje.

2020
11-30
2021
02-28
2021
05-31
2021
08-31
2021
11-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Penger 15 34 57 77 32 27 28 30 33 40 24 7 5 9 19 85 42 54 75 16
Endring (%) 126,41 69,84 34,54 −58,73 −13,88 1,86 6,88 11,05 21,89 −40,43 −71,93 −19,20 65,60 105,15 356,25 −50,32 29,25 36,93 −78,80
Eiendeler Omløp 36 57 72 95 152 148 144 135 160 157 155 151 176 163 177 153 143 143 131 99
Endring (%) 59,54 25,68 31,99 59,78 −2,89 −2,96 −6,05 18,76 −1,91 −1,24 −2,70 16,38 −7,47 8,93 −13,45 −6,85 0,31 −8,20 −24,68
Eiendeler 41 62 80 128 182 178 172 162 164 162 160 156 231 221 204 184 165 155 148 162
Endring (%) 50,49 30,55 59,02 42,54 −2,54 −3,15 −5,77 1,32 −1,70 −1,15 −2,17 47,71 −4,48 −7,66 −9,54 −10,39 −5,94 −4,98 9,59
Forpliktelser 13 12 11 11 12 11 10 9 11 10 10 6 83 58 38 8 10 10 8 8
Endring (%) −4,26 −7,52 1,64 2,41 −4,67 −10,79 −7,47 22,00 −7,12 −8,14 −41,25 1 360,74 −30,25 −34,21 −78,73 18,47 3,89 −23,02 5,96
Egenkapital 28 49 69 117 171 167 162 153 153 151 150 151 148 163 166 176 156 145 140 154
Endring (%) 75,25 39,95 68,39 46,49 −2,39 −2,63 −5,66 0,07 −1,30 −0,67 0,34 −1,61 9,89 1,74 6,30 −11,71 −6,54 −3,75 9,79
Gjeld og aksjer 41 62 80 128 182 178 172 162 164 162 160 156 231 221 204 184 165 155 148 162
Endring (%) 50,49 30,55 59,02 42,54 −2,54 −3,15 −5,77 1,32 −1,70 −1,15 −2,17 47,71 −4,48 −7,66 −9,54 −10,39 −5,94 −4,98 9,59

Source: Capital IQ

Other Listings
US:ORMP USD 2,41
DE:OJU1 € 2,07
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista